• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节过氧化物酶体增殖物激活受体的激酶信号级联反应。

Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.

作者信息

Gelman Laurent, Michalik Liliane, Desvergne Béatrice, Wahli Walter

机构信息

Center for Integrative Genomics, NCCR Frontiers in Genetics, University of Lausanne, Switzerland.

出版信息

Curr Opin Cell Biol. 2005 Apr;17(2):216-22. doi: 10.1016/j.ceb.2005.02.002.

DOI:10.1016/j.ceb.2005.02.002
PMID:15780600
Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in lipid and glucose homeostasis, inflammation and wound healing. In addition to ligand binding, phosphorylation can also regulate PPARs; the biological effects of phosphorylation depend on the stimulus, the kinase, the PPAR isotype, the residue modified, the cell type and the promoter investigated. The study of this dual regulation mode, which allows PPARs to integrate signals conveyed by lipophilic ligands with those coming from the plasma membrane, may ultimately offer new therapeutic strategies.

摘要

过氧化物酶体增殖物激活受体(PPARs)是参与脂质和葡萄糖稳态、炎症及伤口愈合的核受体。除了配体结合外,磷酸化也可调节PPARs;磷酸化的生物学效应取决于刺激因素、激酶、PPAR亚型、修饰的残基、细胞类型以及所研究的启动子。对这种双重调节模式的研究,使PPARs能够将亲脂性配体传递的信号与来自质膜的信号整合起来,最终可能会提供新的治疗策略。

相似文献

1
Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.调节过氧化物酶体增殖物激活受体的激酶信号级联反应。
Curr Opin Cell Biol. 2005 Apr;17(2):216-22. doi: 10.1016/j.ceb.2005.02.002.
2
Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.过氧化物酶体增殖物激活受体配体对丝裂原活化蛋白激酶的激活:非基因组信号传导的一个例子。
Mol Pharmacol. 2005 Oct;68(4):933-41. doi: 10.1124/mol.105.012260. Epub 2005 Jul 14.
3
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.药物洞察:过氧化物酶体增殖物激活受体激动剂的作用机制及治疗应用
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56. doi: 10.1038/ncpendmet0397.
4
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.国际药理学联合会。LX I. 过氧化物酶体增殖物激活受体。
Pharmacol Rev. 2006 Dec;58(4):726-41. doi: 10.1124/pr.58.4.5.
5
Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.过氧化物酶体增殖物激活受体(PPARs)对骨代谢的调控
Fundam Clin Pharmacol. 2007 Jun;21(3):231-44. doi: 10.1111/j.1472-8206.2007.00486.x.
6
Peroxisome proliferator-activated receptors and angiogenesis.过氧化物酶体增殖物激活受体与血管生成。
Nutr Metab Cardiovasc Dis. 2009 Dec;19(11):751-9. doi: 10.1016/j.numecd.2009.04.011. Epub 2009 Jul 23.
7
Peroxisome proliferator-activated receptors and inflammation: take it to heart.过氧化物酶体增殖物激活受体与炎症:牢记于心。
Acta Physiol (Oxf). 2007 Nov;191(3):171-88. doi: 10.1111/j.1748-1716.2007.01752.x.
8
PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.过氧化物酶体增殖物激活受体作为治疗脑缺血/再灌注损伤的新治疗靶点。
Ther Adv Cardiovasc Dis. 2008 Jun;2(3):179-97. doi: 10.1177/1753944708090924.
9
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.从分子作用到生理输出:过氧化物酶体增殖物激活受体是处于关键细胞功能交叉点的核受体。
Prog Lipid Res. 2006 Mar;45(2):120-59. doi: 10.1016/j.plipres.2005.12.002. Epub 2006 Jan 25.
10
Peroxisome proliferator-activated receptors and inflammation.过氧化物酶体增殖物激活受体与炎症
Pharmacol Ther. 2006 Jun;110(3):371-85. doi: 10.1016/j.pharmthera.2005.08.007. Epub 2005 Sep 15.

引用本文的文献

1
Docosahexaenoic Acid as Master Regulator of Cellular Antioxidant Defenses: A Systematic Review.二十二碳六烯酸作为细胞抗氧化防御的主要调节因子:一项系统综述
Antioxidants (Basel). 2023 Jun 15;12(6):1283. doi: 10.3390/antiox12061283.
2
Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.胆红素通过重塑线粒体活性和过氧化物酶体增殖物激活受体α的共调节剂谱重塑小鼠白色脂肪组织。
J Biol Chem. 2020 Jul 17;295(29):9804-9822. doi: 10.1074/jbc.RA120.013700. Epub 2020 May 13.
3
Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma.
骨桥蛋白对非酒精性肝病及相关肝细胞癌发生发展的影响。
Liver Int. 2020 Jul;40(7):1620-1633. doi: 10.1111/liv.14464. Epub 2020 May 30.
4
In Vivo Effects of Lipopolysaccharide on Peroxisome Proliferator-Activated Receptor Expression in Juvenile Gilthead Seabream (Sparus Aurata).脂多糖对幼龄金头鲷(Sparus Aurata)过氧化物酶体增殖物激活受体表达的体内效应
Biology (Basel). 2017 Sep 25;6(4):36. doi: 10.3390/biology6040036.
5
Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells.丝裂原活化蛋白激酶 Erk1/2 的抑制促进 CHO 和 HuH7 细胞中 ATP 结合盒转运蛋白 A1 和 G1 的蛋白降解。
PLoS One. 2013 Apr 25;8(4):e62667. doi: 10.1371/journal.pone.0062667. Print 2013.
6
Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia.NDP-α-MSH 对大鼠星形胶质细胞和小胶质细胞中 PPAR-γ 和 -β 表达及抗炎细胞因子释放的影响。
PLoS One. 2013;8(2):e57313. doi: 10.1371/journal.pone.0057313. Epub 2013 Feb 26.
7
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.抑制 FAAH 和激活 PPAR:治疗认知功能障碍和药物成瘾的新方法。
Pharmacol Ther. 2013 Apr;138(1):84-102. doi: 10.1016/j.pharmthera.2013.01.003. Epub 2013 Jan 16.
8
The role of D-GADD45 in oxidative, thermal and genotoxic stress resistance.D-GADD45 在氧化、热和遗传毒性应激抵抗中的作用。
Cell Cycle. 2012 Nov 15;11(22):4222-41. doi: 10.4161/cc.22545. Epub 2012 Oct 24.
9
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.FAAH 抑制剂 URB597 通过 CB₁-和 FAAH 非依赖性机制有效地降低酪氨酸羟化酶的表达。
Br J Pharmacol. 2013 Jun;169(4):794-807. doi: 10.1111/j.1476-5381.2012.02208.x.
10
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α.合成大麻素 R(+)WIN55,212-2 通过过氧化物酶体增殖物激活受体-α增强干扰素-β的表达。
J Biol Chem. 2012 Jul 20;287(30):25440-53. doi: 10.1074/jbc.M112.371757. Epub 2012 May 31.